Section Arrow
Quote
BCTX.NASDAQ
- Briacell Therapeutics Corp NEW
Quotes are at least 15-min delayed:2026/01/05 04:53 EST
Pre Market
Last
 7.17
0 (0.00%)
Bid
7.17
Ask
7.8
High 7.17 
Low 7.17 
Volume 110 
Regular Hours (Closed)
Last
 7.17
+0.06 (+0.84%)
Day High 
7.3293 
Prev. Close
7.11 
1-M High
13.09 
Volume 
76.00K 
Bid
7.17
Ask
7.8
Day Low
6.88 
Open
7.22 
1-M Low
6.5535 
Market Cap 
13.38M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 8.16 
20-SMA 9.57 
50-SMA 10.05 
52-W High 98.2 
52-W Low 3.410933 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-33.87/-129.50
Enterprise Value
13.40M
Balance Sheet
Book Value Per Share
5.30
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
OTLKOutlook Therapeutics0.66-0.92-58.23%0.58PE
Pre Market 0.6845 +0.0245 +3.71%
MREOMereo BioPharma Group plc0.5104+0.0937+22.49%-- 
Pre Market 0.5539 +0.0435 +8.52%
SLSSELLAS Life Sciences Group4.35+0.58+15.38%-- 
Pre Market 4.81 +0.46 +10.57%
ASBPAspire Biopharma Holdings Inc.0.1369+0.005+3.79%-- 
Pre Market 0.1421 +0.0052 +3.80%
RXRXRecursion Pharmaceuticals4.2+0.11+2.69%-- 
Pre Market 4.28 +0.08 +1.90%
Industry overview quotes are at least 15 minutes delayed
Business Description
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.